How I Beat Cancer—While Still Running My Company

SAUNDRA PELLETIER EVOFEM BIOSCIENCES Evofem Biosciences is a pharmaceuticals startup that makes products supporting women’s reproductive health.
RED, ALERT Saundra Pelletier, expressing a characteristically blunt sentiment, at Evofem’s San Diego offices.

In July 2018, Evofem Biosciences founder and CEO Saundra Pelletier learned she had Stage III breast cancer—while her company was in the midst of a Phase 3 clinical trial of Amphora, its nonhormonal contraceptive gel for women. Pelletier embarked on aggressive treatment for her cancer, undergoing chemotherapy, a double mastectomy, a hysterectomy, and an oophorectomy. At the end of 2018, Evofem announced that Amphora was 98.7 percent effective when used as directed, and 86 percent effective in typical use. Pelletier, who never took a leave of absence, now says she is “done with cancer.” She is again appearing at investor conferences, and

You're reading a preview, sign up to read more.

More from Inc.

Inc.3 min read
The Role Change
Holly Thaggard wasn’t looking for help for her San Antonio–based, kid-friendly sunscreen company, Supergoop. Being open to ideas, though, she met with lots of people. “I just took all those meetings. Investors wanted to get to know us. We were not ob
Inc.2 min readTech
The Carve-Out
He needed capital for some big plans but didn’t want to cede control. That required a different kind of investor.
Inc.4 min read
How I Didn’t Get That MBA (and Still Started A Billion-dollar Company)
In May, the suitcase company Away, which Jen Rubio co-founded with fellow Warby Parker alum Steph Korey in 2015, raised $100 million, at a valuation of $1.4 billion. The company has sold a million suitcases and estimates 2019 revenue will hit $300 mi